Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma

Chinese Medical Journal

Volumn 118, Issue 15, 2005, Pages 1278-1286

  Wang, Jia Xiang ^a   Zhang, Bo ^a   Yu, Jie Kai ^b   Liu, Jian ^b   Yang, Mei Qin ^b   Zheng, Shu ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Artificial neural network; Diagnosis; Hepatocellular carcinoma; Protein fingerprint; SELDI TOF

Indexed keywords

ALPHA FETOPROTEIN; PLASMA PROTEIN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PREDICTION; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BLOOD PROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PEPTIDE MAPPING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 23844530979     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Zhu LY, Hu GX, Li FQ, et al. Application of protein chip system to the detection of primary liver cancer. Bengbu Med Coll 2004;2:74-76.
2. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time-of-flight-mass spectrometry. Electrophoresis 2000;21: 1164-1177.
3. Srinivas PR, Srivastava S, Hanash S. Proteomics in early detection of cancer. Clin Chem 2001;47:1901-1911.
4. Vlahou A, Schellhammer PF, Mendrinos S, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158:1491-1502.
5. Weinberger SR, Boschetti E, Santambien P, et al. Surface enhanced laser desorption-ionization retentate chromatography mass spectrometry (SELDI-RC-MS): a new method for rapid development of process chromatography conditions. J Chromatogr B 2002;782: 307-316.
6. Chapman K. The ProteinChip Biomarker System from Ciphergen Biosystems: a novel roteomics platform for rapid biomarker discovery and validation. Biochem Soc Trans 2002;30:82-87.
7. Bane TK, LeBlanc JF, Lee TD, et al. DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: effect of DNA methylation. Nucleic Acids Res 2002;30:58-69.
8. Melamed P, Koh M, Preklathan P, et al. Multiple mechanisms for Pitx-1 transactivation of a luteinizing hormone beta subunit gene. J Biol Chem 2002;277: 26200-26207.
9. Petricoin EF, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002;94:1576-1578.
10. Qu Y, Adam BL, Yasui Y, et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem 2002;48:1835-1843.
11. Cazares LH, Adam BL, Ward MD, et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 2002;8:2541-2552.
12. Liotta LA, Petricoin 3rd EF, Ardekani AM, et al. General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer. Gynecol Oncol 2003;88: 25-28.
13. Bandera CA, Ye B, Mok SC. New technologies for the identification of markers for early detection of ovarian cancer. Curr Opin Obstet Gynecol 2003;15:51-55.
14. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-577.
15. Li J, Zhang Z, Rosenzweig J, et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48:1296-1304.
16. Carter D, Douglass JF, Comellison CD, et al. Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochemistry 2002;41:6714-6722.
17. Zhukova TA, Johanson RA, Cantor AB, et al. Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 2003;40:267-279.
18. Yu JK, Chen YD, Zheng S. An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J Gastroenterol 2003; 10: 3127-3131.
19. Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev 2003;3:267-272.
20. Srinivas PR, Verma M, Zhao Y, et al. Proteomics for cancer biomarker discovery. Clin Chem 2002;48:1160-1169.
21. Johnson PJ, The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001;5:145-159.
22. Witzigmann H, Geissler F, Benedix F, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 2002;131:34-43.
23. Poon TC, Chan AT, Zee B, et al. Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma. Oncology 2001; 61:275-283.
24. Issaq HJ. The role of separation science in proteomics research. Electrophoresis 2001;22:3629-3638.
25. Jimenez CR, Burlingame AL. Ultramicroanalysis of peptide profiles in biological samples using maldi mass spectrometry. Exp Nephrol 1998;6:421-428.
26. Yates JR. Mass spectrometry and the age of the proteome. J Mass Spectrom 1998;33:1-19.
27. Yates JR. Mass spectrometry from genomics to proteomics. Trends Genet 2000;16:5-8.
28. Smith RD. Probing proteomes-seeing the whole picture? Nat Biotechnol 2000;18:1041-1042.
29. Chakraborty A, Regnier FE. Global internal standard technology for comparative proteomics. Chromatogr 2002;949:173-184.
30. Gevaert K, Vandekerckhove J. Protein identification methods in proteomics. Electrophoresis 2000;21:1145-1154.
31. Yu JK, Yang MQ, Jiang TJ, et al. Application of artificial neural network combining serum tumor markers in colorectal carcinoma diagnosis. J Zhejiang Univ (Med Sci) 2004;33:407-410.